‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Neurology® Podcast
A new paraneoplastic biomarker + Drug pricing controversies: “Evergreening” in pharma
30
00:00:00
/ 00:27:08
30